Mechanisms Driving Resistance to Proteasome Inhibitors Bortezomib, Carfilzomib, and Ixazomib in Multiple Myeloma
Crossref DOI link: https://doi.org/10.1007/978-3-030-73440-4_4
Published Online: 2021-07-24
Published Print: 2021
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bennett, Melissa K.
Pitson, Stuart M.
Wallington-Beddoe, Craig T.
Text and Data Mining valid from 2021-01-01
Version of Record valid from 2021-01-01
Chapter History
First Online: 24 July 2021